Keyphrases
Interferon-α (IFN-α)
100%
Cirrhosis
100%
Non-response
100%
Chronic Hepatitis C Infection
100%
Hepatitis C Virus
40%
Untreated Patients
40%
Liver Disease Progression
40%
Liver Fibrosis Stage
40%
Treatment Nonresponder
40%
Risk Factors
20%
Hepatitis C Treatment
20%
Unexpected Findings
20%
Long-term Clinical Outcome
20%
Overall Survival
20%
Clinical Risk Factors
20%
Liver Biopsy
20%
Cox Proportional Hazards Model
20%
Sustained Virological Response
20%
Long-term Consequences
20%
Treatment Outcome
20%
University Hospital
20%
Retrospective Analysis
20%
Time-dependent Covariates
20%
Response to Treatment
20%
Veterans Affairs Medical Center
20%
Psychosocial Risk Factors
20%
Non-responders
20%
Veterans Affairs
20%
Disease Survival
20%
United States Veterans
20%
Treatment Selection
20%
University Teaching Hospital
20%
Relapser
20%
Interferon-based Therapy
20%
Nursing and Health Professions
Chronic Hepatitis C
100%
Infection
100%
Liver Cirrhosis
100%
Interferon
100%
Hepatitis C
60%
Liver Disease
40%
Disease Exacerbation
40%
Liver Fibrosis
40%
Overall Survival
20%
Proportional Hazards Model
20%
Clinical Outcome
20%
University Hospital
20%
Treatment Outcome
20%
Liver Biopsy
20%
Teaching Hospital
20%
Medicine and Dentistry
Interferon
100%
Chronic Hepatitis C
100%
Infection
100%
Liver Cirrhosis
100%
Veterans Affairs
40%
Hepatitis C Virus
40%
Liver Disease
40%
Disease Exacerbation
40%
Liver Fibrosis
40%
Overall Survival
20%
Liver Biopsy
20%
Proportional Hazards Model
20%
Hepatitis C Treatment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Interferon
100%
Liver Cirrhosis
100%
Chronic Hepatitis C
100%
Liver Fibrosis
40%
Liver Disease
40%
Disease Exacerbation
40%
Hepatitis C Virus
40%
Overall Survival
20%
Hepatitis C
20%
Immunology and Microbiology
interferon
100%
Hepatitis C
100%
Hepatitis C Virus
50%
Overall Survival
25%
Neuroscience
Interferon
100%
Hepatitis C
100%
Hepatitis C Virus
50%